speb/financial-data huggingface dataset:
Financial ratios for AXL.V — quarterly report dated 2025-09-30
Total revenue: 15087692.086330937
Gross profit: 9237864.02877698
Operating income: 3476014.3884892086
Net income: 2222794.2446043165
Capital expenditures: 6681705.755395683
Operating cash flow: 7988559.712230217
Depreciation & amortization: 4103123.7410071944
Net tangible assets: 41643330.21582734
Owner earnings: -355787.76978417207
Return on net tangible assets (%): -0.8543691581345917
Capex to operating income (%): 192.22319037349482
Buffett classification: The Gruesome
Stock price: 0.18705035971223025
P/E ratio: 15.711625640266304
Shares outstanding: 285864348
Book value: 41643330.215827346
P/B ratio: 1.284023848361183
Market cap (USD): 53471029.12230217
Debt to equity: 0.0033569938367841085
Current ratio: 1.010176003307583
Quick ratio: 1.0068330688999405
Effective tax rate (%): 31.543974201181594
Interest coverage ratio: 692.8104387725839
COGS to revenue (%): 38.77218612417039
SG&A to revenue (%): 15.66742762169479
Free cash flow (dilution-adjusted): 982358.9928057556
Buyback yield (%): 0
Retained earnings: -11476388.489208633
Inventory turnover: 142.36397856992787
Receivables turnover: 2.0388997079201823
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.307759075264445
FCF margin (%): 6.51099576518895
Revenue growth (%): 15.158669190706753
Rule of 40 score: 21.669664955895705
Financial ratios for AXL.V — annual report dated 2025-12-31
Total revenue: 57977413.13868613
Gross profit: 36380634.30656934
Operating income: 9670251.09489051
Net income: 1052991.2408759124
Capital expenditures: 31525690.510948904
Operating cash flow: 19564280.2919708
Depreciation & amortization: 15046094.890510948
Net tangible assets: 39741074.45255474
Owner earnings: -15426604.379562043
Return on net tangible assets (%): -38.81778384723654
Capex to operating income (%): 326.0069485435202
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
P/E ratio: 53.503036854341964
Shares outstanding: 285864348
Book value: 39741074.45255474
P/B ratio: 1.4176322594182285
Market cap (USD): 56338229.16788322
Debt to equity: 0.0036860133603520244
Current ratio: 1.056876187536278
Quick ratio: 1.0534906641618709
Effective tax rate (%): 74.83300192494829
Interest coverage ratio: 461.9976286790348
COGS to revenue (%): 37.25033191883836
SG&A to revenue (%): 15.223179789521858
Free cash flow (dilution-adjusted): -12075615.328467153
Buyback yield (%): 0
Retained earnings: -14108245.255474452
Inventory turnover: 272.61373959993733
Receivables turnover: 3.582610739868202
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 18.06301484626221
FCF margin (%): -20.828137501722292
Revenue growth (%): 1.6534211381040287
Rule of 40 score: -19.174716363618263
Financial ratios for AXL.V — quarterly report dated 2025-12-31
Total revenue: 13410027.007299269
Gross profit: 8267471.532846714
Operating income: 956497.810218978
Net income: -2464318.2481751824
Capital expenditures: 5658568.613138686
Operating cash flow: 1270709.4890510947
Depreciation & amortization: 3802296.350364963
Net tangible assets: 39741074.45255474
Owner earnings: -4320590.510948906
Return on net tangible assets (%): -10.871851278472814
Capex to operating income (%): 591.5924273619852
Buffett classification: The Gruesome
Stock price: 0.19708029197080293
P/E ratio: 60.0006890326435
Shares outstanding: 285864348
Book value: 39741074.45255474
P/B ratio: 1.4176322594182285
Market cap (USD): 56338229.16788322
Debt to equity: 0.0036860133603520244
Current ratio: 1.056876187536278
Quick ratio: 1.0534906641618709
Interest coverage ratio: 182.83828659132132
COGS to revenue (%): 38.34858402338331
SG&A to revenue (%): 13.042555529724817
Free cash flow (dilution-adjusted): -4350664.233576641
Buyback yield (%): 0
Retained earnings: -14108245.255474452
Inventory turnover: 64.9139063694913
Receivables turnover: 0.8286486784664042
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 1.786637593674429
FCF margin (%): -32.443366677848694
Revenue growth (%): -11.119428136736634
Rule of 40 score: -43.56279481458533
Financial ratios for BRKM5.SA — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 9.719298245614034
Shares outstanding: 345060365
Market cap (USD): 3353744600.1754384
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRKM5.SA — annual report dated 2022-12-31
Total revenue: 18280113636.363636
Gross profit: 2151136363.6363635
Operating income: 1157575757.5757575
Net income: -63636363.63636363
Capital expenditures: 917803030.3030303
Operating cash flow: 1695454545.4545453
Depreciation & amortization: 896401515.1515151
Net tangible assets: 814393939.3939394
Owner earnings: -85037878.78787875
Return on net tangible assets (%): -10.441860465116275
Capex to operating income (%): 79.28664921465969
Buffett classification: The Gruesome
Stock price: 4.50853889943074
Shares outstanding: 345060365
Book value: 1156818181.81818
P/B ratio: 1.3448250578229461
Market cap (USD): 1555718078.2542696
Debt to equity: 8.81221349050427
Current ratio: 1.4246671628214669
Quick ratio: 0.8497064417431571
Effective tax rate (%): 1846.808510638298
Interest coverage ratio: 1.8365384615384617
COGS to revenue (%): 88.23236875641065
R&D to revenue (%): 0.3874884737720034
SG&A to revenue (%): 5.047710813414975
Free cash flow (dilution-adjusted): 777272727.2727273
Buyback yield (%): 0
Inventory turnover: 6.124047173881777
Receivables turnover: 17.523420479302832
Capitalized R&D asset: 70833333.33333333
ROCI (R&D-adjusted, %): 9.902911613763614
FCF margin (%): 4.252012557113107
Rule of 40 score: 4.252012557113107
Financial ratios for BRKM5.SA — annual report dated 2023-12-31
Total revenue: 14550309278.350517
Gross profit: 622886597.9381443
Operating income: -360824742.26804125
Net income: -944123711.3402063
Capital expenditures: 919175257.7319589
Operating cash flow: -468453608.2474227
Depreciation & amortization: 1073402061.8556702
Net tangible assets: 182268041.23711342
Owner earnings: -789896907.2164949
Return on net tangible assets (%): -433.3710407239819
Buffett classification: The Gruesome
Stock price: 4.525879917184265
Shares outstanding: 345060365
Book value: 676082474.2268028
P/B ratio: 2.3099279092477616
Market cap (USD): 1561701776.1697724
Debt to equity: 18.270509301616386
Current ratio: 1.5285784273699683
Quick ratio: 1.0233526577937455
Interest coverage ratio: -0.4117647058823529
COGS to revenue (%): 95.71908345024018
R&D to revenue (%): 0.5427312275928524
SG&A to revenue (%): 6.21802774589409
Free cash flow (dilution-adjusted): -1402474226.8041239
Buyback yield (%): 0
Retained earnings: -564536082.4742268
Inventory turnover: 5.458424242424243
Receivables turnover: 12.536685023982946
Capitalized R&D asset: 126427405.4982818
ROCI (R&D-adjusted, %): -2.3713180889351015
Rosenberg metric: -21.575290809857215
FCF margin (%): -9.638793237823974
Revenue growth (%): -20.40361691512476
Rule of 40 score: -30.042410152948733
Financial ratios for BRKM5.SA — quarterly report dated 2024-09-30
Operating income: 187661141.80478823
Capital expenditures: 0
Capex to operating income (%): 0
Buffett classification: The Great
Stock price: 3.6703499079189688
Shares outstanding: 345060365
Market cap (USD): 1266492278.9042358
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRKM5.SA — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 1.8707592891760905
Shares outstanding: 345060365
Market cap (USD): 645524883.1502423
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for BRKM5.SA — annual report dated 2024-12-31
Total revenue: 12526051779.935276
Gross profit: 970388349.5145632
Operating income: -160194174.75728157
Net income: -1831715210.355987
Capital expenditures: 599352750.8090615
Operating cash flow: 394012944.98381877
Depreciation & amortization: 800970873.7864078
Net tangible assets: -1321844660.1941748
Owner earnings: -1630097087.3786407
Buffett classification: The Gruesome
Stock price: 1.8707592891760905
Shares outstanding: 345060365
Book value: -692233009.7087383
Market cap (USD): 645524883.1502423
Debt to equity: -17.23281907433379
Current ratio: 1.310024052065648
Quick ratio: 0.8335101867572157
Interest coverage ratio: -0.1820857090307155
COGS to revenue (%): 92.25303897378926
R&D to revenue (%): 0.5981062122954103
SG&A to revenue (%): 5.981062122954102
Free cash flow (dilution-adjusted): -214401294.49838188
Buyback yield (%): 0
Retained earnings: -2270873786.4077673
Inventory turnover: 5.300920427553444
Receivables turnover: 11.902060270602705
Capitalized R&D asset: 151203372.20164818
ROCI (R&D-adjusted, %): -1.333459681252977
Rosenberg metric: 4.400479099596948
FCF margin (%): -1.7116430481456124
Revenue growth (%): -13.912126949955248
Rule of 40 score: -15.62376999810086
Financial ratios for BRKM5.SA — quarterly report dated 2025-03-31
Total revenue: 3924131944.4444447
Gross profit: 227430555.55555555
Operating income: 173611.11111111112
Net income: 121180555.55555557
Capital expenditures: 113368055.55555557
Operating cash flow: -404861111.1111111
Depreciation & amortization: 206770833.33333334
Net tangible assets: -1311284722.2222223
Owner earnings: 214583333.3333333
Return on net tangible assets (%): -16.36435853303323
Capex to operating income (%): 65300
Buffett classification: The Gruesome
Stock price: 1.9097222222222223
P/E ratio: 1.3594785154011462
Shares outstanding: 345060365
Book value: -658854166.666666
Market cap (USD): 658969447.0486112
Debt to equity: -18.17549407114626
Current ratio: 1.3165900930466004
Quick ratio: 0.767113238871086
Effective tax rate (%): 22.549019607843135
Interest coverage ratio: 0.0007722007722007722
COGS to revenue (%): 80.29907534398089
R&D to revenue (%): 0.5574481263549086
SG&A to revenue (%): 5.233818519665531
Free cash flow (dilution-adjusted): -518229166.6666667
Buyback yield (%): 0
Retained earnings: -2314756944.4444447
Inventory turnover: 1.2752951096121417
Receivables turnover: 3.556726986624705
Capitalized R&D asset: 21875000
ROCI (R&D-adjusted, %): 0.1220440219966402
FCF margin (%): -13.206211564836526
Rule of 40 score: -13.206211564836526
Financial ratios for BRKM5.SA — quarterly report dated 2025-06-30
Total revenue: 3258576642.3357663
Gross profit: 66058394.160583936
Operating income: -174817518.24817517
Net income: -48722627.73722627
Capital expenditures: 118248175.18248174
Operating cash flow: -52007299.27007299
Depreciation & amortization: 225729927.00729924
Net tangible assets: -1279744525.547445
Owner earnings: 58759124.08759123
Buffett classification: The Gruesome
Stock price: 1.655109489051095
P/E ratio: 7.881990302549929
Shares outstanding: 345060365
Book value: -594525547.4452553
Market cap (USD): 571112684.4069343
Debt to equity: -20.064456721915292
Current ratio: 1.206980487613364
Quick ratio: 0.6847395076753955
Interest coverage ratio: -0.5792019347037485
COGS to revenue (%): 97.97278378227026
R&D to revenue (%): 0.6048048384387076
SG&A to revenue (%): 6.787254298034384
Free cash flow (dilution-adjusted): -170255474.45255473
Buyback yield (%): 0
Retained earnings: -2481204379.5620437
Inventory turnover: 1.3152157570290182
Receivables turnover: 2.665223880597015
Capitalized R&D asset: 34364279.19708029
ROCI (R&D-adjusted, %): -1.4025354404953088
Rosenberg metric: -7.377013092341559
FCF margin (%): -5.22484179873439
Revenue growth (%): -16.96057399524836
Rule of 40 score: -22.18541579398275
Financial ratios for BRKM5.SA — quarterly report dated 2025-09-30
Total revenue: 3251691729.323308
Gross profit: 81954887.21804512
Operating income: -150000000
Net income: -4887218.045112782
Capital expenditures: 238345864.6616541
Operating cash flow: -128383458.64661653
Depreciation & amortization: 203947368.42105263
Net tangible assets: -1234586466.1654134
Owner earnings: -39285714.28571427
Buffett classification: The Gruesome
Stock price: 1.2349624060150375
P/E ratio: 6.306528080155491
Shares outstanding: 345060365
Book value: -596428571.4285717
Market cap (USD): 426136578.58082706
Debt to equity: -19.929719508351706
Current ratio: 1.1754205440229062
Quick ratio: 0.6317108088761632
Interest coverage ratio: -0.49906191369606007
COGS to revenue (%): 97.47962309960113
R&D to revenue (%): 0.6994623966703278
SG&A to revenue (%): 6.433897913174172
Free cash flow (dilution-adjusted): -366729323.30827063
Buyback yield (%): 0
Retained earnings: -2560338345.8646617
Inventory turnover: 1.3875586274993827
Receivables turnover: 2.903978512674165
Capitalized R&D asset: 43167490.46429944
ROCI (R&D-adjusted, %): -1.2121759320363648
Rosenberg metric: 0.8065998329156229
FCF margin (%): -11.278108561188507
Revenue growth (%): -0.21128590081352758
Rule of 40 score: -11.489394462002034
Financial ratios for BRKM5.SA — quarterly report dated 2025-12-31
Total revenue: 2938138686.1313868
Gross profit: -100729927.00729926
Operating income: 20620437.956204377
Net income: -1876824817.518248
Capital expenditures: 102737226.27737226
Operating cash flow: -164233576.64233574
Depreciation & amortization: 211678832.1167883
Net tangible assets: -3505474452.5547442
Owner earnings: -1767883211.678832
Capex to operating income (%): 498.2300884955753
Buffett classification: The Gruesome
Stock price: 1.4165170556552962
Shares outstanding: 345060365
Book value: -3011313868.613138
Market cap (USD): 488783892.2531418
Debt to equity: -4.321657980850806
Current ratio: 0.7570739469889104
Quick ratio: 0.49796111193992737
Interest coverage ratio: 0.07508305647840531
COGS to revenue (%): 103.42835848705047
R&D to revenue (%): 0.6521334078628656
SG&A to revenue (%): 7.291472579342898
Free cash flow (dilution-adjusted): -266970802.919708
Buyback yield (%): 0
Retained earnings: -4361678832.116788
Inventory turnover: 1.5980232223395066
Receivables turnover: 2.057635782747604
Capitalized R&D asset: 40902955.38115361
ROCI (R&D-adjusted, %): 0.2517685590917188
Rosenberg metric: -8.032092658502744
FCF margin (%): -9.086392149555927
Revenue growth (%): -9.642766574836818
Rule of 40 score: -18.729158724392747
Financial ratios for BRKM5.SA — annual report dated 2025-12-31
Total revenue: 12904562043.79562
Gross profit: 283941605.839416
Operating income: -299635036.49635035
Net income: -1802919708.029197
Capital expenditures: 571532846.7153285
Operating cash flow: -766423357.6642336
Depreciation & amortization: 852737226.2773722
Net tangible assets: -3505474452.5547442
Owner earnings: -1521715328.467153
Buffett classification: The Gruesome
Stock price: 1.4165170556552962
Shares outstanding: 345060365
Book value: -3011313868.613138
Market cap (USD): 488783892.2531418
Debt to equity: -4.321657980850806
Current ratio: 0.7570739469889104
Quick ratio: 0.49796111193992737
Interest coverage ratio: -0.3127619047619048
COGS to revenue (%): 97.79968041630724
R&D to revenue (%): 0.6504800825826887
SG&A to revenue (%): 6.620755970982932
Free cash flow (dilution-adjusted): -1337956204.379562
Buyback yield (%): 0
Retained earnings: -4361678832.116788
Inventory turnover: 6.636695134823913
Receivables turnover: 9.037316293929713
Capitalized R&D asset: 160197192.53410795
ROCI (R&D-adjusted, %): -3.799901862053434
Rosenberg metric: -9.162507291387493
FCF margin (%): -10.368086881513639
Revenue growth (%): 3.0217842821523107
Rule of 40 score: -7.346302599361328
Financial ratios for CBLL — annual report dated 2024-12-31
Total revenue: 65444000
Gross profit: 56750000
Operating income: -39709000
Net income: -40455000
Capital expenditures: 1340000
Operating cash flow: -35043000
Depreciation & amortization: 1141000
Net tangible assets: 191165000
Owner earnings: -40654000
Return on net tangible assets (%): -21.26644521748228
Buffett classification: The Gruesome
Stock price: 25.88
Shares outstanding: 37942700
Book value: 191165000
P/B ratio: 5.136699061020584
Market cap (USD): 981957076
Debt to equity: 0.11487458478277927
Current ratio: 16.727384710139347
Quick ratio: 16.19331742243437
Interest coverage ratio: -19.934236947791163
COGS to revenue (%): 13.284640303159954
R&D to revenue (%): 20.723060937595502
SG&A to revenue (%): 126.66860216368192
Free cash flow (dilution-adjusted): -41794000
Buyback yield (%): 0
Retained earnings: -166944000
Inventory turnover: 1.253279515640767
Receivables turnover: 6.016179444750874
Capitalized R&D asset: 21978840
ROCI (R&D-adjusted, %): -15.392512846031131
Rosenberg metric: 2.0663702056698168
FCF margin (%): -63.862233359819086
Revenue growth (%): 44.707573244886675
Rule of 40 score: -19.154660114932412
Financial ratios for CBLL — quarterly report dated 2024-12-31
Capital expenditures: 357000
Buffett classification: The Gruesome
Stock price: 25.88
Shares outstanding: 37942700
Market cap (USD): 981957076
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBLL — quarterly report dated 2025-03-31
Total revenue: 20491000
Gross profit: 18007000
Operating income: -14207000
Net income: -12777000
Capital expenditures: 148000
Operating cash flow: -11403000
Depreciation & amortization: 335000
Net tangible assets: 180881000
Owner earnings: -12590000
Return on net tangible assets (%): -6.960377264610434
Buffett classification: The Gruesome
Stock price: 19.21
Shares outstanding: 37942700
Book value: 180881000
P/B ratio: 4.029606575593899
Market cap (USD): 728879267
Debt to equity: 0.12028902980412537
Current ratio: 17.36286028230919
Quick ratio: 16.808976417885216
Interest coverage ratio: -30.16348195329087
COGS to revenue (%): 12.122395197891757
R&D to revenue (%): 20.721292274657166
SG&A to revenue (%): 136.48919037626274
Free cash flow (dilution-adjusted): -14030000
Buyback yield (%): 0
Retained earnings: -179721000
Inventory turnover: 0.37906302456889973
Receivables turnover: 1.813523320647845
Capitalized R&D asset: 4246000
ROCI (R&D-adjusted, %): -5.525549737880834
FCF margin (%): -68.46908398809234
Rule of 40 score: -68.46908398809234
Financial ratios for CBLL — quarterly report dated 2025-06-30
Total revenue: 21199000
Gross profit: 18682000
Operating income: -14952000
Net income: -13643000
Capital expenditures: 71000
Operating cash flow: -7533000
Depreciation & amortization: 324000
Net tangible assets: 172155000
Owner earnings: -13390000
Return on net tangible assets (%): -7.777874589759229
Buffett classification: The Gruesome
Stock price: 18.73
Shares outstanding: 37942700
Book value: 172155000
P/B ratio: 4.128063495106154
Market cap (USD): 710666771
Debt to equity: 0.12519531817257704
Current ratio: 13.306647129345944
Quick ratio: 12.907020114559744
Interest coverage ratio: -31.345911949685533
COGS to revenue (%): 11.873201566111609
R&D to revenue (%): 22.887872069437236
SG&A to revenue (%): 135.77055521486864
Free cash flow (dilution-adjusted): -10640000
Buyback yield (%): 0
Retained earnings: -193364000
Inventory turnover: 0.4195
Receivables turnover: 1.721816114359974
Capitalized R&D asset: 7696820
ROCI (R&D-adjusted, %): -6.554148515827558
Rosenberg metric: 0.15897315120113048
FCF margin (%): -50.19104674748809
Revenue growth (%): 3.455175442877361
Rule of 40 score: -46.735871304610725
Financial ratios for CBLL — quarterly report dated 2025-09-30
Total revenue: 22589000
Gross profit: 19942000
Operating income: -14647000
Net income: -13465000
Capital expenditures: 369000
Operating cash flow: -11098000
Depreciation & amortization: 391000
Net tangible assets: 164081000
Owner earnings: -13443000
Return on net tangible assets (%): -8.192904723886372
Buffett classification: The Gruesome
Stock price: 11.49
Shares outstanding: 37942700
Book value: 164081000
P/B ratio: 2.656990285285926
Market cap (USD): 435961623
Debt to equity: 0.13008209360011214
Current ratio: 12.64543776371308
Quick ratio: 12.248285864978904
Interest coverage ratio: -30.514583333333334
COGS to revenue (%): 11.718092877064059
R&D to revenue (%): 22.05940944707601
SG&A to revenue (%): 131.06379211120455
Free cash flow (dilution-adjusted): -14816000
Buyback yield (%): 0
Retained earnings: -206829000
Inventory turnover: 0.4394090305444887
Receivables turnover: 1.8464116396926598
Capitalized R&D asset: 9635020
ROCI (R&D-adjusted, %): -7.401163546143119
Rosenberg metric: 0.25968672712283597
FCF margin (%): -65.58944619062376
Revenue growth (%): 6.556913061936884
Rule of 40 score: -59.03253312868688
Financial ratios for CBLL — annual report dated 2025-12-31
Total revenue: 89063000
Gross profit: 78274000
Operating income: -58402000
Net income: -53412000
Capital expenditures: 767000
Operating cash flow: -40808000
Depreciation & amortization: 1341000
Net tangible assets: 155336000
Owner earnings: -52838000
Return on net tangible assets (%): -34.01529587474893
Buffett classification: The Gruesome
Stock price: 21.93
Shares outstanding: 37942700
Book value: 155336000
P/B ratio: 5.3566681966833185
Market cap (USD): 832083411
Debt to equity: 0.14340526342895402
Current ratio: 9.729963522668056
Quick ratio: 9.350182386659718
Interest coverage ratio: -30.900529100529102
COGS to revenue (%): 12.113896904438432
R&D to revenue (%): 21.49377407004031
SG&A to revenue (%): 131.9661363304627
Free cash flow (dilution-adjusted): -53798000
Buyback yield (%): 0
Retained earnings: -220356000
Inventory turnover: 1.4803787047200878
Receivables turnover: 5.9166279147013885
Capitalized R&D asset: 31197890
ROCI (R&D-adjusted, %): -25.580468858008352
Rosenberg metric: 1.5870815513935999
FCF margin (%): -60.404432817219266
Revenue growth (%): 36.09039789743903
Rule of 40 score: -24.314034919780234
Financial ratios for CBLL — quarterly report dated 2025-12-31
Total revenue: 24784000
Gross profit: 21643000
Operating income: -14596000
Net income: -13527000
Capital expenditures: 179000
Operating cash flow: -10774000
Depreciation & amortization: 291000
Net tangible assets: 155336000
Owner earnings: -13415000
Return on net tangible assets (%): -8.636117834886955
Buffett classification: The Gruesome
Stock price: 21.93
Shares outstanding: 37942700
Book value: 155336000
P/B ratio: 5.3566681966833185
Market cap (USD): 832083411
Debt to equity: 0.14340526342895402
Current ratio: 9.729963522668056
Quick ratio: 9.350182386659718
Interest coverage ratio: -31.593073593073594
COGS to revenue (%): 12.673499031633312
R&D to revenue (%): 20.424467398321497
SG&A to revenue (%): 125.79486765655261
Free cash flow (dilution-adjusted): -14312000
Buyback yield (%): 0
Retained earnings: -220356000
Inventory turnover: 0.43098243688254667
Receivables turnover: 1.6464492127815054
Capitalized R&D asset: 10001770
ROCI (R&D-adjusted, %): -7.769838725341336
Rosenberg metric: 0.34136062612883805
FCF margin (%): -57.746933505487405
Revenue growth (%): 9.717118951702156
Rule of 40 score: -48.02981455378525
Financial ratios for CBOX.L — annual report dated 2022-03-31
Total revenue: 43374797.368421055
Gross profit: 20830475
Operating income: 9258878.94736842
Net income: 8304757.894736842
Capital expenditures: 1470936.8421052631
Operating cash flow: 6968784.2105263155
Depreciation & amortization: 1287642.105263158
Net tangible assets: 21934855.263157893
Owner earnings: 8121463.157894737
Return on net tangible assets (%): 37.025378378200045
Capex to operating income (%): 15.88677042292832
Buffett classification: The Great
Stock price: 0.021710526315789475
P/E ratio: 0.1150260091868707
Shares outstanding: 44000000
Book value: 22076003.94736842
P/B ratio: 0.043271561292169886
Market cap (USD): 955263.1578947369
Debt to equity: 0.2571189615683569
Current ratio: 2.8657543719815277
Quick ratio: 2.273738521083177
Effective tax rate (%): 18.426381210560496
Interest coverage ratio: 84.58646471931723
COGS to revenue (%): 51.97562579239714
SG&A to revenue (%): 6.595325820724295
Free cash flow (dilution-adjusted): 6116734.2105263155
Buyback yield (%): 0
Retained earnings: 16767090.789473685
Inventory turnover: 6.939746148216163
Receivables turnover: 16.459322341094275
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 32.3895233515561
FCF margin (%): 14.102046768245177
Rule of 40 score: 14.102046768245177
Financial ratios for CBOX.L — annual report dated 2023-03-31
Total revenue: 42964124.69135802
Gross profit: 21202802.469135802
Operating income: 7233909.876543209
Net income: 5230458.024691357
Capital expenditures: 1918774.074074074
Operating cash flow: 7759091.358024691
Depreciation & amortization: 1397062.962962963
Net tangible assets: 21407616.049382716
Owner earnings: 4708746.913580246
Return on net tangible assets (%): 21.995662210673952
Capex to operating income (%): 26.524716326587384
Buffett classification: The Good
Stock price: 0.012839506172839505
P/E ratio: 0.10800933091099121
Shares outstanding: 44000000
Book value: 21900438.27160494
P/B ratio: 0.025795751874856776
Market cap (USD): 564938.2716049382
Debt to equity: 0.22192154111578463
Current ratio: 2.7945100771846723
Quick ratio: 2.1979963192465783
Effective tax rate (%): 22.17105070994809
Interest coverage ratio: 36.50894737497975
COGS to revenue (%): 50.649983861068584
SG&A to revenue (%): 10.854936365082771
Free cash flow (dilution-adjusted): 5337817.283950617
Buyback yield (%): 0
Retained earnings: 17147728.395061728
Inventory turnover: 6.316164192517784
Receivables turnover: 19.957231318701485
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 25.31589310000959
FCF margin (%): 12.423893940109263
Revenue growth (%): -0.9468002203556634
Rule of 40 score: 11.477093719753599
Financial ratios for CBOX.L — annual report dated 2024-03-31
Total revenue: 47905016.4556962
Gross profit: 25240386.075949367
Operating income: 7585077.215189873
Net income: 5897069.620253164
Capital expenditures: 1064058.2278481012
Operating cash flow: 7944635.443037975
Depreciation & amortization: 1598774.6835443038
Net tangible assets: 23510007.594936706
Owner earnings: 6431786.075949367
Return on net tangible assets (%): 27.357652055095745
Capex to operating income (%): 14.028311085841269
Buffett classification: The Great
Stock price: 0.018734177215189874
P/E ratio: 0.13978193417241133
Shares outstanding: 44000000
Book value: 24431251.898734175
P/B ratio: 0.03373972815167376
Market cap (USD): 824303.7974683545
Debt to equity: 0.1851453075068978
Current ratio: 2.5031333563081954
Quick ratio: 2.089452145277709
Effective tax rate (%): 25.644572987603237
Interest coverage ratio: 19.274686781285684
COGS to revenue (%): 47.311601282315955
SG&A to revenue (%): 12.544078851391664
Free cash flow (dilution-adjusted): 6122368.354430379
Buyback yield (%): 0
Retained earnings: 19225753.16455696
Inventory turnover: 6.9055829943868465
Receivables turnover: 11.002453423047001
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 24.4897107602169
FCF margin (%): 12.780223883426705
Revenue growth (%): 11.500040556701977
Rule of 40 score: 24.280264440128683
Financial ratios for CBOX.L — quarterly report dated 2024-09-30
Capital expenditures: 0
Net tangible assets: 23914132
Buffett classification: The Gruesome
Stock price: 0.021866666666666663
Shares outstanding: 44000000
Book value: 25346733.333333336
P/B ratio: 0.037958869124489404
Market cap (USD): 962133.3333333331
Debt to equity: 0.1767007977359344
Current ratio: 2.3781352437016268
Quick ratio: 1.9108040682701974
Buyback yield (%): 0
Retained earnings: 19760190.666666668
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CBOX.L — annual report dated 2025-03-31
Total revenue: 55559254.54545455
Gross profit: 29164864.935064934
Operating income: 9547836.363636363
Net income: 5679600
Capital expenditures: 2639110.3896103897
Operating cash flow: 8566712.987012986
Depreciation & amortization: 1787090.909090909
Net tangible assets: 14048084.415584415
Owner earnings: 4827580.519480519
Return on net tangible assets (%): 34.36468899720579
Capex to operating income (%): 27.64092606008243
Buffett classification: The Good
Stock price: 0.022207792207792208
P/E ratio: 0.17204430895535902
Shares outstanding: 44000000
Book value: 35055024.67532467
P/B ratio: 0.027874544838950598
Market cap (USD): 977142.8571428572
Debt to equity: 0.7963887497240425
Current ratio: 1.330537538932364
Quick ratio: 1.03972027373783
Effective tax rate (%): 28.923538991116445
Interest coverage ratio: 16.956627234083776
COGS to revenue (%): 47.50673821369514
SG&A to revenue (%): 11.588028188273821
Free cash flow (dilution-adjusted): 4305894.805194804
Buyback yield (%): 0
Retained earnings: 20469658.44155844
Inventory turnover: 5.556291278475621
Receivables turnover: 17.21377033190947
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 15.106762964728897
FCF margin (%): 7.750094633958837
Revenue growth (%): 15.977946895889664
Rule of 40 score: 23.7280415298485
Financial ratios for CBOX.L — quarterly report dated 2025-03-31
Capital expenditures: 0
Net tangible assets: 14048084.415584415
Buffett classification: The Gruesome
Stock price: 0.022207792207792208
Shares outstanding: 44000000
Book value: 35055024.67532467
P/B ratio: 0.027874544838950598
Market cap (USD): 977142.8571428572
Debt to equity: 0.7963887497240425
Current ratio: 1.330537538932364
Quick ratio: 1.03972027373783
Buyback yield (%): 0
Retained earnings: 20469658.44155844
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CING — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 662.4
Shares outstanding: 13469036
Market cap (USD): 8921889446.4
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CING — annual report dated 2022-12-31
Total revenue: 0
Operating income: -17502280
Net income: -17676232
Capital expenditures: 153420
Operating cash flow: -15882808
Depreciation & amortization: 394011
Net tangible assets: 3882022
Owner earnings: -17435641
Return on net tangible assets (%): -449.13812956237757
Buffett classification: The Gruesome
Stock price: 240
Shares outstanding: 13469036
Book value: 3882022
P/B ratio: 832.7022979261839
Market cap (USD): 3232568640
Debt to equity: 1.5110792777578284
Current ratio: 1.1221840063883186
Quick ratio: 1.1221840063883186
Free cash flow (dilution-adjusted): -16837024
Buyback yield (%): 0
Retained earnings: -69408496
Receivables turnover: 0
Capitalized R&D asset: 8995280
ROCI (R&D-adjusted, %): -85.94132488049644
Rule of 40 score: 0
Financial ratios for CING — annual report dated 2023-12-31
Total revenue: 0
Operating income: -22759304
Net income: -23534947
Capital expenditures: 224096
Operating cash flow: -15034543
Depreciation & amortization: 582918
Net tangible assets: -6869429
Owner earnings: -23176125
Buffett classification: The Gruesome
Stock price: 91.8
Shares outstanding: 13469036
Book value: -6869429
Market cap (USD): 1236457504.8
Debt to equity: -0.5109945819368684
Current ratio: 0.05658197146306692
Quick ratio: 0.05658197146306692
Free cash flow (dilution-adjusted): -16071309
Buyback yield (%): 0
Retained earnings: -92943443
Receivables turnover: 0
Capitalized R&D asset: 21520141.6
ROCI (R&D-adjusted, %): -104.34910000701842
Rule of 40 score: 0
Financial ratios for CING — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 5.04
Shares outstanding: 13469036
Market cap (USD): 67883941.44
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CING — annual report dated 2024-12-31
Total revenue: 0
Operating income: -15645265
Net income: -16559605
Capital expenditures: 211800
Operating cash flow: -18451387
Depreciation & amortization: 653090
Net tangible assets: 7455505
Owner earnings: -16118315
Return on net tangible assets (%): -216.19347046243013
Buffett classification: The Gruesome
Stock price: 4.93
Shares outstanding: 13469036
Book value: 7455505
P/B ratio: 8.906485540550237
Market cap (USD): 66402347.48
Debt to equity: 0.6839347569346409
Current ratio: 2.5463667802671104
Quick ratio: 2.5463667802671104
Free cash flow (dilution-adjusted): -19658671
Buyback yield (%): 0
Retained earnings: -109925120
Receivables turnover: 0
Capitalized R&D asset: 22794221.08
ROCI (R&D-adjusted, %): -53.57326940849742
Rule of 40 score: 0
Financial ratios for CING — quarterly report dated 2024-12-31
Capital expenditures: 198462
Buffett classification: The Gruesome
Stock price: 4.93
Shares outstanding: 13469036
Market cap (USD): 66402347.48
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CING — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -3705626
Net income: -3852678
Capital expenditures: 0
Operating cash flow: -4608282
Depreciation & amortization: 165291
Net tangible assets: 5930820
Owner earnings: -3687387
Return on net tangible assets (%): -62.173308244053935
Buffett classification: The Gruesome
Stock price: 4.3
Shares outstanding: 13469036
Book value: 5930820
P/B ratio: 9.765404244269764
Market cap (USD): 57916854.8
Debt to equity: 0.8568423927888555
Current ratio: 1.8708532573948322
Quick ratio: 1.8708532573948322
Free cash flow (dilution-adjusted): -4965931
Buyback yield (%): 0
Retained earnings: -112291871
Receivables turnover: 0
Capitalized R&D asset: 2222626
ROCI (R&D-adjusted, %): -24.49972517053088
Rule of 40 score: 0
Financial ratios for CING — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -4649939
Net income: -4788735
Capital expenditures: 5925
Operating cash flow: -4795257
Depreciation & amortization: 146989
Net tangible assets: 5511874
Owner earnings: -4647671
Return on net tangible assets (%): -84.32106757157366
Buffett classification: The Gruesome
Stock price: 4.07
Shares outstanding: 13469036
Book value: 5511874
P/B ratio: 9.945614961445056
Market cap (USD): 54818976.52
Debt to equity: 1.1940938780530905
Current ratio: 1.5183502365379242
Quick ratio: 1.5183502365379242
Free cash flow (dilution-adjusted): -4988572
Buyback yield (%): 0
Retained earnings: -117080606
Receivables turnover: 0
Capitalized R&D asset: 4190098.42
ROCI (R&D-adjusted, %): -32.86045313854815
Rule of 40 score: 0
Financial ratios for CING — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -5995544
Net income: -7341062
Capital expenditures: 0
Operating cash flow: -4244354
Depreciation & amortization: 106782
Net tangible assets: 3473686
Owner earnings: -7234280
Return on net tangible assets (%): -208.259468472395
Buffett classification: The Gruesome
Stock price: 3.92
Shares outstanding: 13469036
Book value: 3473686
P/B ratio: 15.199595219602461
Market cap (USD): 52798621.12
Debt to equity: 1.3181413058059939
Current ratio: 1.2636772954727626
Quick ratio: 1.2636772954727626
Free cash flow (dilution-adjusted): -4837178
Buyback yield (%): 0
Retained earnings: -126102121
Receivables turnover: 0
Capitalized R&D asset: 5391639.71
ROCI (R&D-adjusted, %): -57.21541527571772
Rule of 40 score: 0
Financial ratios for CING — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -5585948
Net income: -6272910
Capital expenditures: 156213
Operating cash flow: -3597289
Depreciation & amortization: 121832
Net tangible assets: 2508907
Owner earnings: -6307291
Return on net tangible assets (%): -251.39596645072936
Buffett classification: The Gruesome
Stock price: 4.34
Shares outstanding: 13469036
Book value: 2508907
P/B ratio: 23.299235978057375
Market cap (USD): 58455616.239999995
Debt to equity: 3.5021445593638982
Current ratio: 1.1644230251754524
Quick ratio: 1.1644230251754524
Free cash flow (dilution-adjusted): -4139467
Buyback yield (%): 0
Retained earnings: -132375031
Receivables turnover: 0
Capitalized R&D asset: 4801782.350000001
ROCI (R&D-adjusted, %): -63.80334103035603
Rule of 40 score: 0
Financial ratios for CING — annual report dated 2025-12-31
Total revenue: 0
Operating income: -19938057
Net income: -22449911
Capital expenditures: 162138
Operating cash flow: -17245182
Depreciation & amortization: 540894
Net tangible assets: 2508907
Owner earnings: -22071155
Return on net tangible assets (%): -879.7119622209991
Buffett classification: The Gruesome
Stock price: 4.34
Shares outstanding: 13469036
Book value: 2508907
P/B ratio: 23.299235978057375
Market cap (USD): 58455616.239999995
Debt to equity: 3.5021445593638982
Current ratio: 1.1644230251754524
Quick ratio: 1.1644230251754524
Free cash flow (dilution-adjusted): -18931148
Buyback yield (%): 0
Retained earnings: -132375031
Receivables turnover: 0
Capitalized R&D asset: 21215174.87
ROCI (R&D-adjusted, %): -83.67351367254184
Rule of 40 score: 0
Financial ratios for CMPS — annual report dated 2021-12-31
Capital expenditures: 451351.35135135136
Buffett classification: The Gruesome
Stock price: 22.1
Shares outstanding: 134949320
Market cap (USD): 2982379972
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMPS — annual report dated 2022-12-31
Total revenue: 0
Operating income: -115637349.39759037
Net income: -110246987.95180723
Capital expenditures: 718072.2891566266
Operating cash flow: -127049397.59036145
Depreciation & amortization: 397590.3614457832
Net tangible assets: 218409638.5542169
Owner earnings: -110567469.87951808
Return on net tangible assets (%): -50.62389673433363
Buffett classification: The Gruesome
Stock price: 8.03
Shares outstanding: 134949320
Book value: 218409638.55421686
P/B ratio: 4.961516564805826
Market cap (USD): 1083643039.6
Debt to equity: 0.01063548102383054
Current ratio: 12.288471402923825
Quick ratio: 12.288471402923825
Free cash flow (dilution-adjusted): -143578313.25301206
Buyback yield (%): 0
Retained earnings: -314633734.9397591
Receivables turnover: 0
Capitalized R&D asset: 78377108.43373494
ROCI (R&D-adjusted, %): -21.32122395991641
Rule of 40 score: 0
Financial ratios for CMPS — annual report dated 2023-12-31
Total revenue: 0
Operating income: -157017721.51898733
Net income: -149954430.37974682
Capital expenditures: 81012.6582278481
Operating cash flow: -123260759.49367088
Depreciation & amortization: 306329.11392405065
Net tangible assets: 285751898.73417723
Owner earnings: -149729113.92405063
Return on net tangible assets (%): -52.398291870437305
Buffett classification: The Gruesome
Stock price: 8.75
Shares outstanding: 134949320
Book value: 285751898.73417723
P/B ratio: 4.13227892878659
Market cap (USD): 1180806550
Debt to equity: 0.14640477709263588
Current ratio: 13.328708426851662
Quick ratio: 13.328708426851662
Interest coverage ratio: -56.28130671506352
Free cash flow (dilution-adjusted): -145213924.0506329
Buyback yield (%): 0
Retained earnings: -480518987.34177214
Receivables turnover: 0
Capitalized R&D asset: 163294941.13161507
ROCI (R&D-adjusted, %): -22.40298586476812
Rule of 40 score: 0
Financial ratios for CMPS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.3
Shares outstanding: 134949320
Market cap (USD): 850180716
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMPS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.78
Shares outstanding: 134949320
Market cap (USD): 510108429.59999996
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CMPS — annual report dated 2024-12-31
Total revenue: 0
Operating income: -196385000
Net income: -193902500
Capital expenditures: 0
Operating cash flow: -148982500
Depreciation & amortization: 291250
Net tangible assets: 193368750
Owner earnings: -193611250
Return on net tangible assets (%): -100.12540806102331
Buffett classification: The Gruesome
Stock price: 3.78
Shares outstanding: 134949320
Book value: 193368750
P/B ratio: 2.638008621351692
Market cap (USD): 510108429.59999996
Debt to equity: 0.2081062736352177
Current ratio: 5.9175388052681095
Quick ratio: 5.9175388052681095
Interest coverage ratio: -35.0765795936593
Free cash flow (dilution-adjusted): -173378750
Buyback yield (%): 0
Retained earnings: -668415000
Receivables turnover: 0
Capitalized R&D asset: 248887322.365411
ROCI (R&D-adjusted, %): -33.84497252619995
Rule of 40 score: 0
Financial ratios for CMPS — quarterly report dated 2025-03-31
Total revenue: 0
Operating income: -53464935.064935066
Net income: -23200000
Capital expenditures: 0
Operating cash flow: -59294805.19480519
Depreciation & amortization: 48051.94805194805
Net tangible assets: 253853246.75324675
Owner earnings: -23151948.051948052
Return on net tangible assets (%): -9.120209549438012
Buffett classification: The Gruesome
Stock price: 2.86
Shares outstanding: 134949320
Book value: 253853246.75324675
P/B ratio: 1.5203865230652744
Market cap (USD): 385955055.2
Debt to equity: 0.16387932489883203
Current ratio: 10.182606086869564
Quick ratio: 10.182606086869564
Interest coverage ratio: -36.62633451957296
Free cash flow (dilution-adjusted): -64405194.8051948
Buyback yield (%): 0
Retained earnings: -717657142.8571428
Receivables turnover: 0
Capitalized R&D asset: 40103896.103896104
ROCI (R&D-adjusted, %): -6.431345099411698
Rule of 40 score: 0
Financial ratios for CMPS — quarterly report dated 2025-06-30
Total revenue: 0
Operating income: -52939726.02739726
Net income: -52606849.31506849
Capital expenditures: 0
Operating cash flow: -52998630.1369863
Depreciation & amortization: 216438.35616438356
Net tangible assets: 222678082.19178084
Owner earnings: -52390410.95890411
Return on net tangible assets (%): -23.527421488111717
Buffett classification: The Gruesome
Stock price: 2.8
Shares outstanding: 134949320
Book value: 222678082.19178084
P/B ratio: 1.696880502476085
Market cap (USD): 377858096
Debt to equity: 0.21708344867890866
Current ratio: 8.822874106230847
Quick ratio: 8.822874106230847
Interest coverage ratio: -33.57602085143353
Free cash flow (dilution-adjusted): -57924657.53424657
Buyback yield (%): 0
Retained earnings: -809587671.2328768
Receivables turnover: 0
Capitalized R&D asset: 68410706.28002135
ROCI (R&D-adjusted, %): -9.03032045864984
Rule of 40 score: 0
Financial ratios for CMPS — quarterly report dated 2025-09-30
Total revenue: 0
Operating income: -49475675.675675675
Net income: -186104054.05405405
Capital expenditures: 0
Operating cash flow: -47440540.54054054
Depreciation & amortization: 20270.27027027027
Net tangible assets: 50798648.64864865
Owner earnings: -186083783.7837838
Return on net tangible assets (%): -366.31640552259853
Buffett classification: The Gruesome
Stock price: 5.73
Shares outstanding: 134949320
Book value: 50798648.64864868
P/B ratio: 15.222050668085437
Market cap (USD): 773259603.6
Debt to equity: 0.9359687159160432
Current ratio: 1.2275917953912383
Quick ratio: 1.2275917953912383
Interest coverage ratio: -33.13303167420814
Free cash flow (dilution-adjusted): -51774324.324324325
Buyback yield (%): 0
Retained earnings: -984751351.3513514
Receivables turnover: 0
Capitalized R&D asset: 77992495.63653673
ROCI (R&D-adjusted, %): -33.25619247228357
Rule of 40 score: 0
Financial ratios for CMPS — quarterly report dated 2025-12-31
Total revenue: 0
Operating income: -79545945.94594595
Net income: -126862162.16216217
Capital expenditures: 0
Operating cash flow: -51064864.86486486
Depreciation & amortization: 8108.108108108108
Net tangible assets: -71416216.21621622
Owner earnings: -126854054.05405407
Buffett classification: The Gruesome
Stock price: 6.9
Shares outstanding: 134949320
Book value: -71416216.2162162
Market cap (USD): 931150308
Debt to equity: -0.6629389948531639
Current ratio: 0.7727758832906234
Quick ratio: 0.7727758832906234
Interest coverage ratio: -51.77132805628848
Free cash flow (dilution-adjusted): -54918918.918918915
Buyback yield (%): 0
Retained earnings: -1111613513.5135136
Receivables turnover: 0
Capitalized R&D asset: 78862277.86005184
ROCI (R&D-adjusted, %): -278.6991442266976
Rule of 40 score: 0
Financial ratios for CMPS — annual report dated 2025-12-31
Total revenue: 0
Operating income: -236878378.3783784
Net income: -389002702.7027027
Capital expenditures: 0
Operating cash flow: -212486486.4864865
Depreciation & amortization: 291891.8918918919
Net tangible assets: -71416216.21621622
Owner earnings: -388710810.8108108
Buffett classification: The Gruesome
Stock price: 6.9
Shares outstanding: 134949320
Book value: -71416216.2162162
Market cap (USD): 931150308
Debt to equity: -0.6629389948531639
Current ratio: 0.7727758832906234
Quick ratio: 0.7727758832906234
Interest coverage ratio: -38.806730130617666
Free cash flow (dilution-adjusted): -230851351.35135135
Buyback yield (%): 0
Retained earnings: -1111613513.5135136
Receivables turnover: 0
Capitalized R&D asset: 296301963.04738283
ROCI (R&D-adjusted, %): -88.19981324687056
Rule of 40 score: 0
Financial ratios for CX — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.64
Shares outstanding: 1442952453
Market cap (USD): 9581204287.92
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CX — annual report dated 2022-12-31
Total revenue: 755704008.2219938
Gross profit: 230472764.6454265
Operating income: 69938335.04624872
Net income: 45477903.39157245
Capital expenditures: 38797533.40184995
Operating cash flow: 70298047.27646454
Depreciation & amortization: 55087358.68448099
Net tangible assets: 63771839.67112024
Owner earnings: 61767728.67420349
Return on net tangible assets (%): 96.8573730862208
Capex to operating income (%): 55.47391623806025
Buffett classification: The Good
Stock price: 3.96
P/E ratio: 125.64545169729357
Shares outstanding: 1442952453
Book value: 560585817.0606372
P/B ratio: 10.193072211211366
Market cap (USD): 5714091713.88
Debt to equity: 0.8089650747089558
Current ratio: 0.8160836639019113
Quick ratio: 0.5151460512080779
Effective tax rate (%): 29.47368421052631
Interest coverage ratio: 2.553470919324578
COGS to revenue (%): 69.50224398204814
SG&A to revenue (%): 8.09873521011832
Free cash flow (dilution-adjusted): 23741007.194244605
Buyback yield (%): 0.09982353290092154
Retained earnings: 218191161.35662898
Inventory turnover: 6.124026363091672
Receivables turnover: 6.827298050139276
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 6.511650160279412
FCF margin (%): 3.141574867401061
Rule of 40 score: 3.141574867401061
Financial ratios for CX — annual report dated 2023-12-31
Total revenue: 967787610.619469
Gross profit: 326607669.6165192
Operating income: 114808259.58702065
Net income: 11740412.979351033
Capital expenditures: 50265486.72566372
Operating cash flow: 134985250.73746315
Depreciation & amortization: 69203539.82300885
Net tangible assets: 134159292.03539823
Owner earnings: 30678466.076696157
Return on net tangible assets (%): 22.86719437115215
Capex to operating income (%): 43.78211716341213
Buffett classification: The Good
Stock price: 7.58
P/E ratio: 931.6179603713216
Shares outstanding: 1442952453
Book value: 714808259.5870208
P/B ratio: 15.301417473909952
Market cap (USD): 10937579593.74
Debt to equity: 0.6178606800924397
Current ratio: 0.7375478927203065
Quick ratio: 0.47391688770999113
Effective tax rate (%): 90.87481146304677
Interest coverage ratio: 3.3961605584642234
COGS to revenue (%): 66.2521336259449
SG&A to revenue (%): 8.814923189465985
Free cash flow (dilution-adjusted): 72507374.63126844
Buyback yield (%): 0
Retained earnings: 261238938.05309737
Inventory turnover: 6.07490217998882
Receivables turnover: 6.8492693110647185
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.989698341571579
FCF margin (%): 7.492075103633261
Revenue growth (%): 28.06437442305772
Rule of 40 score: 35.55644952669098
Financial ratios for CX — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 6.01
Shares outstanding: 1442952453
Market cap (USD): 8672144242.529999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CX — annual report dated 2024-12-31
Total revenue: 778623364.0329617
Gross profit: 262142510.90644693
Operating income: 88366456.6165778
Net income: 46534173.533688806
Capital expenditures: 47842947.1643238
Operating cash flow: 95928259.81580223
Depreciation & amortization: 59815802.22976249
Net tangible assets: 137178865.7295201
Owner earnings: 58507028.599127494
Return on net tangible assets (%): 42.65017667844524
Capex to operating income (%): 54.14152495885902
Buffett classification: The Good
Stock price: 5.58
P/E ratio: 173.02713417507937
Shares outstanding: 1442952453
Book value: 604798836.6456617
P/B ratio: 13.312979787455012
Market cap (USD): 8051674687.74
Debt to equity: 0.5369880580267693
Current ratio: 0.8233749179251477
Quick ratio: 0.579612606697308
Effective tax rate (%): 6.760847628657922
Interest coverage ratio: 3.1162393162393163
COGS to revenue (%): 66.3325655232522
SG&A to revenue (%): 9.13278964078939
Free cash flow (dilution-adjusted): 33737275.81192438
Buyback yield (%): 0
Retained earnings: 254338342.2200679
Inventory turnover: 7.175084175084175
Receivables turnover: 7.19346171070309
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 8.596218229829773
FCF margin (%): 4.332939052480857
Revenue growth (%): -19.54604961985674
Rule of 40 score: -15.213110567375882